Growing up in India, Chirag Patel had no doctors in his family, but his parents hoped that would change. Encouraged to pursue medicine — and moved by his grandparents’ chronic health struggles in a place where access to care was limited — he took their wishes to heart.
Years later, during his medical residency, hepatitis C had reached epidemic proportions, with no readily available cure. The experience left a lasting mark and ultimately led him to a fellowship in hepatology.
When Patel later moved to Chattanooga, he immediately saw a major gap in local liver care and knew then that he wanted to take up that fight. As part of Galen Medical Group, he began connecting transplant centers and treating some of the sickest patients in the region. Over the past 23 years, he has helped facilitate nearly 220 liver transplants care for hundreds of more patients.
Patel now oversees seven active clinical trials for new treatments and has served on advisory boards for four pharmaceutical companies. This research brings cutting‑edge care to local patients — often those who might not be able to otherwise afford medications.
He’s witnessed the positive change firsthand. In his early years, Patel says he was seeing 60 to 70 hepatitis C patients each week. Thanks to better treatments discovered in 2013, that number has dropped to only three or four.
